Home › Articles › Volume 8, Issue 2 › Molecular Detection of Rifampicin and Isoniazid Resi...
Moradabad, India
Original Article
Pulmonary Medicine

Molecular Detection of Rifampicin and Isoniazid Resistant Mycobacterium Tuberculosis and Their Associated Mutation Pattern From Smear Positive Sputum Samples From a Tertiary Care Centre of West U.P.


Volume 8, Issue 2, Pages 5-8

Authors

Mazher Maqusood1, Umar Farooq2, Sana Nudrat3
Affiliation:
1Associate Professor, Department of Pulmonary Medicine, Teerthankar Mahaveer Medical College, Moradabad. 244001, U.P. INDIA,
2Professor and Head Dept. of Microbiology, Teerthankar Mahaveer Medical College, Moradabad. 244001, U.P. INDIA,
3Ph.D. Scholar Dept. of Microbiology, Teerthankar Mahaveer Medical College, Moradabad. 244001, U.P. INDIA.

Corresponding Author

Mazher Maqusood

Abstract

Background: Delayed diagnosis and treatment done on its basis has been proven to be a factor causing increase in rate of MDR TB. So we used GenoType MTBDR plus assay® in order to determine rate of MDR-TB, Isoniazid and Rifampicin mono resistance and common mutation pattern associated with them from our area in order to provide better patient care and reduce rate of MDR-TB. Subjects and Methods: This was a cross sectional prospective study comprising of 150 smear positive sputum samples collected during period of 11⁄2 years from January 2018 to April 2019. Results: Out of total 150 smear positive samples 97 were from male patients and 53 from female patients. Rate of MDR TB found was 18/150 (12%), rifampicin mono resistance and isoniazid mono resistance was 10/150 (6.6%) and 13/150 (8.6%) respectively. Highest percentage of MDR TB was seen among defaulter cases (27.3%) followed by failure cases (25%) and relapse cases (12.5%). Mutation pattern most commonly reported for rifampicin is S531L in rpoB gene at codon 530-533 and for isoniazid was S315T1 in katG gene at codon 315. Conclusion: Problem of MDR-TB is continuously rising, so rapid detection of TB along with drug sensitivity is the need of hour and should be given utmost priority for END TB strategy. The GenoType MTBDR plus (LPAs) assay approved by world health organization is highly specific (≥99%) and sensitive (≥97%) diagnostic test for the detection of first line drugs resistance and is a rapid and reliable diagnostic tool.

Keywords

MDR-TB, LPA, rpo B, katG gene.

History

Received 01 June 2019

Accepted 01 June 2019

DOI

10.21276/ajmr.2019.8.2.PM2

Author Notes

Corresponding Author: Dr. Mazher Maqusood, Associate Professor, Department of Pulmonary Medicine, Teerthankar Mahaveer Medical College, Moradabad. 244001, U.P. INDIA.

Open Access

It is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits authors to retain ownership of the copyright for their content, and allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. https://creativecommons.org/licenses/by/4.0/

Copyright

Copyright: © the author(s), 2019.

Cite this Article

Formats

                                                
Actions
Download PDF
Metrics
8
Downloads
8
Views
Journal
Journal Asian Journal of Medical Research
Volume Volume 8
Issue Issue 2
Year 2019

Purchase access plans

Select the plan that best fits your need

Loading plans...

Statistics:

Views: 0
Downloads: 0

Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.

Quick Links

For Authors

© 2026 Asian Journal of Medical Research. All Rights Reserved.Designed and Developed By Kryoni